Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: European Research Projects of Neuroscience

University of Ottawa

$167,700.00

Therapeutic and Enhancement Uses of Neuroscientific Knowledge: A Question of Individual Autonomy?

FY 2017-18

Summary
Neuroscientific research is providing novel and promising technologies for diagnosis, treatment and prognosis in the context of neurological and psychiatric conditions. While this research has been aimed at addressing disorders or deficits, the same interventions (e.g. externally applied electrical or magnetic stimulation of the brain) can often be turned toward enhancement uses in people without disorders or deficits, as they are currently conceived. These brain-based interventions may alter our perceptions of the agency and capacity of patients, and accordingly of their responsibility. People may be reproached for untreated problematic behaviours that could be avoided through treatment, or for the unintended behavioural consequences of therapeutic or enhancement uses of brain-interventions where they are applied. At the same time, a complex web of potential responsibility draws together the individual who chooses (or refuses) to use these interventions, the maker, marketer and medical personnel who provide the interventions, third parties who may be benefited or harmed by the use or non-use of the interventions, and the broader society that stands to be affected in more diffuse ways. The Canadian part of this interdisciplinary biomedical ethics project will provide a comprehensive analysis of the complexity of ethical and legal responsibility in relation to brain-based interventions intended to modify human capacities but that may also pose some risks of harm to the individual and to others. In particular, this project will provide patients, clinicians, and health policy-makers (e.g. drug and device licensing authorities) with the careful analysis necessary to understand the potential legal ramifications of these treatment decisions. These issues will form an important part of the context within which clinicians and patients will have to navigate as they consider whether to use the fruits of this neuroscientific research.
Program
Team Grant: European Research Projects of Neuroscience
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
366460
Name
Chandler Jennifer A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
The Academy of Finland; German Federal Ministry of Research, Technology and Space (Berlin)
Instname2
Health Services and Policy Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Special Cases
Projecttitle
Therapeutic and Enhancement Uses of Neuroscientific Knowledge: A Question of Individual Autonomy?
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$167,700
Cihrequipment2
$0
Programname2
Team Grant: European Research Projects of Neuroscience
Keyworddelim
Autonomy; Brain Computer Interface; Capacity; Disability; Human Capacity Enhancement; Legal Responsibility; Professional Negligence; Therapy Enhancement Distinction
Abstract
Neuroscientific research is providing novel and promising technologies for diagnosis, treatment and prognosis in the context of neurological and psychiatric conditions. While this research has been aimed at addressing disorders or deficits, the same interventions (e.g. externally applied electrical or magnetic stimulation of the brain) can often be turned toward enhancement uses in people without disorders or deficits, as they are currently conceived. These brain-based interventions may alter our perceptions of the agency and capacity of patients, and accordingly of their responsibility. People may be reproached for untreated problematic behaviours that could be avoided through treatment, or for the unintended behavioural consequences of therapeutic or enhancement uses of brain-interventions where they are applied. At the same time, a complex web of potential responsibility draws together the individual who chooses (or refuses) to use these interventions, the maker, marketer and medical personnel who provide the interventions, third parties who may be benefited or harmed by the use or non-use of the interventions, and the broader society that stands to be affected in more diffuse ways. The Canadian part of this interdisciplinary biomedical ethics project will provide a comprehensive analysis of the complexity of ethical and legal responsibility in relation to brain-based interventions intended to modify human capacities but that may also pose some risks of harm to the individual and to others. In particular, this project will provide patients, clinicians, and health policy-makers (e.g. drug and device licensing authorities) with the careful analysis necessary to understand the potential legal ramifications of these treatment decisions. These issues will form an important part of the context within which clinicians and patients will have to navigate as they consider whether to use the fruits of this neuroscientific research.
Competitiondate
201705
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chandler, Jennifer A
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $167,700~ $0~